Aarey Drugs and Pharmaceuticals Limited issued a regulatory notice regarding the outcome of its board meeting held on August 6, 2026. The board approved the allotment of 2,52,0000 equity shares of Rs. 10 each following the conversion of fully convertible warrants. This conversion was executed upon receiving 75% of the issue price, amounting to Rs. 12,05,82,000, from both promoter and non-promoter category allottees.

Aarey Drugs and Pharmaceuticals Limited is an established player engaged in the manufacturing of bulk drugs and acting as dealers of chemicals and solvents. The company operates its manufacturing facilities out of Tarapur, Boisar, with its head office located in Mumbai. Over recent periods, the company has focused on optimizing its capital structure through preferential issues and warrant conversions to support its operational footprint in the pharmaceutical sector.